Cancer, infectious and chronic diseases continue to exact a high toll on human life. More than 560 000 people die each year from cancer and associated complications in the United States alone, and the emergence of a new and deadly swine flu strain in 2009 provides ample illustration of this reality. The advent of recombinant, biologically derived products (biologics) has revolutionized the practice of medicine through the use of monoclonal antibodies (mAbs), vaccines and other therapeutic proteins.
展开▼
